| Financial Year |
March 31 2023 |
| Monetary Funds |
274,232,764.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
171,439,080.85 |
| Advances to Suppliers |
143,056,098.90 |
| Other Receivables |
16,780,078.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
476,292,124.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
63,261,782.66 |
| Other Current Assets |
31,669,996.82 |
| Total Current Assets |
1,176,731,926.53 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
550,385.99 |
| Fixed Assetes |
966,482,717.53 |
| Under-construction Projects |
116,988,874.31 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
200,486,540.78 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,894,457.35 |
| Deferred Income Tax Assets |
32,917,561.37 |
| Other Non-Current Assets |
96,188,266.76 |
| Sub-Total of Non-Current Assets |
1,435,561,216.98 |
| Total Assets |
2,612,293,143.51 |
| Short-Term Loans |
471,181,019.34 |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,156,178.00 |
| Accounts Payable |
216,242,333.77 |
| Accounts Received In Advance |
3,800,000.00 |
| Employee Compensation Payable |
76,467,012.75 |
| Taxes Payable |
28,491,432.22 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
162,157,882.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
11,998,653.76 |
| Other Current Liabilities |
11,297,741.57 |
| Sub-Total of Current Liabilities |
1,071,651,557.94 |
| Long-term Loans |
236,780,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
2,847,448.82 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
268,338,660.33 |
| Total Liabilities |
1,339,990,218.27 |
| Paid-In Capital(Or Share Stock) |
128,604,990.00 |
| Capital Surplus |
392,904,713.42 |
| Surplus Reserve |
64,344,495.00 |
| LESS:Treasury Stock |
79,077,848.67 |
| Undistributed Profits |
751,796,176.23 |
| Minority Stockholder's Interest |
13,730,399.26 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,258,572,525.98 |
| Owner's Equity（Stockholder's Equity） |
1,272,302,925.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,612,293,143.51 |
